SCHEMBL4948817

SCHEMBL4948817

O=C(COc1cccc(Cl)c1Cl)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 1/20 0.49
HTR1A P08908 8/20 0.47
HTR2A P28223 8/20 0.47
HTR7 P34969 8/20 0.47
HTR6 P50406 8/20 0.47
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HTT P42858 1/20 0.43
TSHR P16473 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
OPRL1 P41146 1/20 0.43
TP53 P04637 1/20 0.42
MC4R P32245 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4952515 0.93 MEN1 (0.59) MEN1KMT2APOLBHTR1AHTR2A
SCHEMBL4953313 0.89 HTR1A (0.49) MEN1KMT2APOLBHTR1AHTR2A
SCHEMBL4952781 0.85 HTT (0.48) MEN1KMT2APOLBHTR1AHTR2A
SCHEMBL4952920 0.85 HTT (0.58) MEN1KMT2AHTR1AHTR2AHTR7
SCHEMBL4952671 0.84 ALDH1A1 (0.55) HTR1AHTR2AHTR7HTR6KDM4E
SCHEMBL4948806 0.84 MEN1 (0.50) MEN1KMT2APOLBHTR1AHTR2A
SCHEMBL4954789 0.84 OPRM1 (0.45) MEN1KMT2APOLBHTR1AHTR2A
SCHEMBL13994625 0.84 KMT2A (0.54) MEN1KMT2AHTR1AHTR2AHTR7
SCHEMBL4952842 0.84 FKBP1A (0.56) MEN1KMT2APOLBHTR1AHTR2A
SCHEMBL4952724 0.84 OPRM1 (0.45) MEN1KMT2APOLBHTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US claimed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 MEN1 2976/4885KMT2A 4099/4885POLB 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.